Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility and Advanced AI-driven Analysis

July 11, 2024
Virtual (Webinar)

Session Introduction

This webinar on ophthalmology clinical trials explores strategies for improving patient access and precision analysis using artificial intelligence (AI). Attendees will learn about vendor-agnostic, multi-modality platforms, AI-enabled workflows, and best practices for eCOA implementation in various trial settings. Case studies will demonstrate AI’s transformative impact on dry age-related macular degeneration (AMD), diabetic retinopathy (DR), and macular edema (ME) trials, enhancing traditional metrics and improving study workflows.

Register to learn about strategies integrating AI in ophthalmology clinical trials.


Todd Rudo headshot

Todd Rudo, M.D.

Chief Medical Officer at Clario

Dr. Todd Rudo is EVP and Chief Medical Officer at Clario, providing medical and scientific leadership across the organization. He has nearly 20 years of clinical cardiology and pharmaceutical research experience, with a career predominantly focused on drug safety.
Dr. Rudo has board certifications in cardiology, cardiac electrophysiology, nuclear cardiology, adult echocardiography and internal medicine. His team provides expert consulting to clients on scientific and regulatory strategy and ensures Clario’s product portfolio is scientifically robust, generating high-quality clinical trial endpoint data. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials while maintaining focus on the customer experience, including minimizing patient and site burden.


Amit Vasanji, Ph.D.

Vice President, Medical and Scientific Affairs at Clario

Dr. Vasanji has over 20 years of experience in basic and clinical research image acquisition, processing, analysis, visualization and biomedical software engineering across multiple modalities and therapeutic areas. His research has been published in a broad array of peer-reviewed journals and he is frequently invited to speak at international events on effective workflow design and algorithm-based biomarker development for imaging-based clinical trials. In his current role at Clario, Amit oversees the scientific feasibility and design of Clario’s imaging platform and is responsible for the development and integration of customized image analysis algorithms into clinical trial workflows.

Kelly Dumais headshot

Kelly Dumais, Ph.D.

Director, eCOA Science and Consulting at Clario

Dr. Kelly Dumais is a Scientist with over 13 years of experience in behavioral and life science research. She has expertise in the implementation of electronic clinical outcome assessments (eCOAs) and the development and validation of patient-reported outcomes (PROs) to support labeling claims. Dr. Dumais is currently the Director of eCOA Science and Consulting at Clario, a global data and technology company that helps to minimize risk in clinical trials. She consults on best practices for questionnaire design and eCOA design/use to drive data integrity and patient engagement and develops custom site rater training and participant training for improving accuracy in COA reporting and improving inter-and intra-rater reliability.